Despite bigger losses and rising R&D costs, analysts see strong potential for Neurogene, with price targets far above current levels. This is a classic case for high-growth biotech: steep losses ...

Growth in high-margin licensing and early water-treatment sales turned losses into gains for Birchtech last quarter, impressing investors. This isn’t just a lucky break for Birchtech. The company’s ...

The company swung to quarterly earnings, with strong licensing revenue and a push into commercial water solutions fueling the upswing. After years of groundwork, Birchtech finally seems to be hitting ...

Despite steep losses and dwindling liquidity, analysts remain upbeat on Senti Biosciences, with buy ratings and a price target far above current levels. Senti Biosciences reported a hefty ...

Tech and utilities dragged the S&P/TSX down as investors questioned valuations and Fed policy, echoing bigger market jitters in the US. Canada’s main stock market just clocked its steepest one-day ...

Chip gear maker beat analyst forecasts but faces export challenges and slower demand—yet it’s planning for a stronger 2026. Despite reporting lower year-over-year earnings and sales, both numbers ...

Small gains for fintech firms balanced out losses in tech and education, leaving the S&P Asia 50 ADR Index nearly unchanged for the day but down for the week. US-listed Asian stocks finished Thursday ...

Strong gains in services, manufacturing, and mining powered Malaysia’s GDP to 5.2% growth, as lower rates and steady household spending helped offset global trade headwinds. For markets: Broader ...

Inhibrx Biosciences reported disappointing Q3 numbers but highlighted encouraging clinical results and set sights on a key drug approval next year. The biotech’s third-quarter net loss widened to ...

Global market jitters sent the franc climbing against the euro and dollar, while traders weighed rate cut prospects and responded to shifting central bank signals. Stock and bond selloffs kicked off ...

Join the newsletter that everyone in finance secretly reads. 1M+ subscribers, 100% free. The revenue drop was intentional, with P3 Health Partners paring back parts of its network and payer ...

Rubber prices edged higher in Asia, supported by a cheap yen, potential supply disruptions in Thailand, and rising demand from Brazil’s auto sector. For markets: Rubber stands tall amid shaky global ...